Hindustan Syringes achieves production capacity of over 1 bn AD syringes
Hindustan Syringes achieves production capacity of over 1 bn AD syringes
Share:

Medical syringe conglomerate Hindustan Syringes and Medical Devices Ltd (HMD) on Saturday announced that it has achieved its target to create capacities to produce over 1 billion auto-disable (AD) syringes for Covid vaccination. The company said that it has also achieved a milestone of producing over 1 crore pieces of assorted size of syringes daily.

Commenting on the development, Rajiv Nath, Managing Director of Hindustan Syringes & Medical Devices Ltd, said: "Atmanirbhar Bharat was the centerpiece of Prime Minister Narendra Modi's Independence Day address last year and this year on India's 75th Independence Day, we are delighted that HMD has simultaneously reached two significant milestones towards it"

He added that "HMD's top priority right now is to help the government to combat the pandemic. It had been ensuring continuity of the supply chain and its manufacturing plants to ensure no shortages in India for its critically needed disposable devices during the Covid crisis".

The conglomerate said that it has 'made India proud' with its global recognition as a 'key international supplier' of critically needed syringes to the COVAX facility of WHO (via UNICEF), Brazil and even Japan for Covid vaccination.

Good Sign! Not a single active corona patient in 15 districts of UP

Andhra Pradesh: Over 130 of Lorries trapped in Krishna river

Sri Lanka trade deficit widens in June driven by rising import

 

Join NewsTrack Whatsapp group
Related News